Aethlon Medical announced a private placement and warrant inducement, resulting in aggregate gross proceeds of $3.3 million.
The offering is expected to close on or about December 8, 2025.
Maxim Group LLC is serving as the sole placement agent for the offering.
Private Placement Details
595,897 shares of common stock and warrants to purchase up to 1,042,820 shares of common stock were offered at an effective price of $4.03 per share.
Warrant Inducement Agreement
Investor agreed to exercise outstanding warrants at an amended exercise price of $4.03 and receive unregistered warrants for additional shares.
Gross Proceeds Estimate
Approximately $3.3 million gross proceeds are expected from the private placement and warrant inducement.
- The private placement and warrant inducement aim to raise capital for Aethlon Medical's ongoing operations and product development.
- The agreement with the institutional investor demonstrates confidence in Aethlon's future prospects.
Aethlon Medical's successful pricing of the private placement and warrant inducement reflects investor interest and provides additional funding for the Company's growth initiatives.